Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2017 ∙ Walters, J. A. Tang, J. N. Poole, P. Wood-Baker, R.

Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
  • Economic aspects
  • Safety
Methodological quality (AMSTAR 2):
High
2017 ∙ Hungerford, D. Smith, K. Tucker, A. Iturriza-Gomara, M. Vivancos, R. McLeonard, C. Cunliffe, N. French, N.

Population effectiveness of the pentavalent and monovalent rotavirus vaccines: A systematic review and meta-analysis of observational studies

  • Newborn
  • Children
  • Rotavirus
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2017 ∙ Kessels, J. A. Recuenco, S. Navarro-Vela, A. M. Deray, R. Vigilato, M. Ertl, H. Durrheim, D. Rees, H. Nel, L. H. Abela-Ridder, B. Briggs, D.

Pre-exposure rabies prophylaxis: a systematic review

  • Newborn
  • Children
  • Adolescents
  • Rabies
  • Efficacy/effectiveness
  • Safety
  • Administration
  • Economic aspects
Methodological quality (AMSTAR 2):
Critically low
2017 ∙ Harder, Thomas Koch, Judith Wichmann, Ole Hellenbrand, Wiebke

Predicted vs observed effectiveness of outer membrane vesicle (OMV) vaccines against meningococcal serogroup B disease: Systematic review

  • Newborn
  • Children
  • Adolescents
  • Adults
  • Meningococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
High
2017 ∙ Mulley, W. R. Le, S. T. Ives, K. E.

Primary seroresponses to double-dose compared with standard-dose hepatitis B vaccination in patients with chronic kidney disease: a systematic review and meta-analysis

  • All age groups
  • Hepatitis B
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2017 ∙ Bi, Q. Ferreras, E. Pezzoli, L. Legros, D. Ivers, L. C. Date, K. Qadri, F. Digilio, L. Sack, D. A. Ali, M. Lessler, J. Luquero, F. J. Azman, A. S. Cavailler, P. Date, K. Sreenivasan, N. Matzger, H. Luquero, F. Grais, R. Wiesner, L. Ko, M. Rouzier, V. Peak, C. Qadri, F. Landegger, J. Lynch, J. Azman, A. Sack, D. Henkens, M. Ciglenecki, I. Ivers, L. Diggle, E. Weiss, M. Hinman, A. Maina, K. Mirza, I. Gimeno, G. Levine, M.

Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis

  • All age groups
  • Cholera
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2017 ∙ Connors, John T. Slotwinski, Kate L. Hodges, Eric A.

Provider-parent Communication When Discussing Vaccines: A Systematic Review

  • Parents/caregivers
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2017 ∙ Bonanni, P. Grazzini, M. Niccolai, G. Paolini, D. Varone, O. Bartoloni, A. Bartalesi, F. Santini, M. G. Baretti, S. Bonito, C. Zini, P. Mechi, M. T. Niccolini, F. Magistri, L. Pulci, M. B. Boccalini, S. Bechini, A.

Recommended vaccinations for asplenic and hyposplenic adult patients

  • Adults
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2017 ∙ Belongia, E. A. Skowronski, D. M. McLean, H. Q. Chambers, C. Sundaram, M. E. De Serres, G.

Repeated annual influenza vaccination and vaccine effectiveness: review of evidence

  • All age groups
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2017 ∙ Bosch-Capblanch, X. Zuske, M. K. Auer, C.

Research on subgroups is not research on equity attributes: Evidence from an overview of systematic reviews on vaccination

  • All age groups
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
Loading...